Associate Scientist
Edgewise Therapeutics
Molly Madden is an associate scientist with Edgewise Therapeutics headquartered in Boulder, Colorado. Molly earned a BA in Molecular, Cellular, and Developmental Biology from the University of Colorado. Currently, Molly works as a clinical pharmacologist supporting the clinical development of small molecules intended for rare diseases such as Duchenne muscular dystrophy and hypertrophic cardiomyopathy.